Pole vault queen Isinbayeva aims to make Russian anti-doping system best in worldSport December 08, 15:17
Lavrov regrets Obama administration continues unfriendly steps against RussiaRussian Politics & Diplomacy December 08, 14:48
Putin: New Customs Code of EAEU scheduled for approval on December 26Business & Economy December 08, 14:46
Russian team’s priority is to maintain leading positions at 2018 Winter OlympicsSport December 08, 14:43
Official says early presidential election in Russia 'technically impossible'Russian Politics & Diplomacy December 08, 14:37
Gazprom signs contract for construction of first line of Turkish Stream’s offshore segmentBusiness & Economy December 08, 14:28
Putin surprised human rights activists pay little attention to Russian hospital's bombingRussian Politics & Diplomacy December 08, 14:24
Diplomat says confrontation and self-isolation not Russia’s path on world stageRussian Politics & Diplomacy December 08, 14:11
Russian top diplomat says time to stop sabotaging Minsk agreementsRussian Politics & Diplomacy December 08, 13:57
ST. PETERSBURG, January 20. /TASS/. The US pharmaceuticals producer Pfizer will launch a joint production with St. Petersburg-based scientific and technological pharmaceutical company Polysan, a source familiar with the matter told TASS, adding that the sides are expected to sign the agreement in end-January.
"In end-January an agreement will be signed on production of Pfizer medicines in St. Petersburg and its localization. At the same time a joint production with Polysan pharm producer will be announced," the source said.
An official in St. Petersburg confirmed to TASS such an agreement is being prepared, saying that the signing is planned for January 25.
A representative of Polysan said when commenting the information that the company’s policy "is aimed at development of local pharmaceutical industry, including via cooperation with leading global pharma producers."
Polysan has manufacturing plants in St. Petersburg and Belgorod. In St. Petersburg, the company produces 4 its own brands of medicines, as well as a neurological drug within partnership with German Stada. In 2015, Polysan signed a 10-year agreement with German pharmaceuticals giant Bayer.
Polysan products are supplied to all regions in Russia, to the former CIS countries, South East Asia, Latin America and Mongolia.